Phospho-Cdc25b (Ser149) Antibody

Basic Research Questions

• What is Cdc25B and why is its Ser149 phosphorylation significant?

  Cdc25B is a dual specificity phosphatase that functions as a dosage-dependent inducer of mitotic progression. It plays a critical role in cell cycle regulation by activating the M-phase promoting factor (MPF) through direct dephosphorylation of CDK1 (Cdc2) at Tyr15 . The phosphorylation of Ser149 is particularly significant as it represents a key regulatory mechanism:

  • Ser149 has been identified as a phosphorylation target of Protein Kinase A (PKA) in vitro and in vivo

  • Phosphorylation at this site shows clear cell cycle dependence: phosphorylated during G1/S phases and dephosphorylated during G2/M phases

  • This phosphorylation state directly affects Cdc25B's subcellular localization and activity

  • Recent research suggests Ser149 may serve as a potential binding site for 14-3-3ε, further regulating Cdc25B function

• How does Cdc25B-Ser149 phosphorylation affect cell cycle regulation?

  Phosphorylation at Ser149 exerts profound effects on cell cycle regulation through multiple mechanisms:

  Cell Cycle Phase	Ser149 Status	Cdc25B Location	Functional Impact
  G1/S	Phosphorylated	Cytoplasmic	Inactive; MPF remains inhibited
  G2/M	Dephosphorylated	Nuclear	Active; promotes MPF activation

  Studies in fertilized mouse eggs demonstrate that overexpression of phospho-deficient Cdc25B-S149A mutant initiated efficient MPF activation by direct dephosphorylation of Cdc2-Tyr15, triggering mitosis earlier than wild-type Cdc25B . Conversely, the phosphomimetic Cdc25B-S149D mutant showed no significant difference compared to control groups, suggesting that phosphorylation maintains Cdc25B in an inactive state . This regulatory mechanism serves as a critical checkpoint preventing premature mitotic entry.

• What experimental applications are appropriate for Phospho-Cdc25b (Ser149) Antibody?

  Phospho-Cdc25b (Ser149) Antibody serves as a valuable tool for investigating cell cycle regulation. The primary applications include:

  • Western Blotting (WB): The most common application with recommended dilutions ranging from 1:500-1:1000

  • Immunohistochemistry (IHC-P): Effective for tissue sections with suggested dilutions of 1:100-500

  • Immunofluorescence (IF): Useful for cellular localization studies at dilutions of 1:50-200

  Research applications include:

  • Monitoring phosphorylation status during cell cycle progression

  • Investigating PKA-mediated regulation of Cdc25B activity

  • Studying subcellular trafficking of Cdc25B

  • Examining interactions between phosphorylated Cdc25B and binding partners like 14-3-3ε

  • Analyzing the effects of mutations or treatments on Ser149 phosphorylation

  The antibody specifically detects endogenous levels of Cdc25B protein only when phosphorylated at serine 149, making it ideal for phosphorylation-specific studies .

• What is the relationship between PKA and Cdc25B-Ser149 phosphorylation?

  Protein Kinase A (PKA) has been established as a direct upstream regulator of Cdc25B through Ser149 phosphorylation. Key findings from the literature demonstrate:

  • PKA acts as a negative regulator of M-phase promoting factor (MPF) by phosphorylating Cdc25B

  • LC-MS/MS analysis identified Ser149, along with Ser229 and Ser321, as specific PKA phosphorylation sites in vitro

  • The consensus sequence around Ser149 (F-R-S-L-P) is consistent with PKA recognition motifs

  • In fertilized mouse eggs, Cdc25B-Ser149 phosphorylation patterns correlate with expected PKA activity levels during cell cycle progression

  • Inhibition of PKA leads to decreased Ser149 phosphorylation, suggesting direct regulation in vivo

  This PKA-mediated phosphorylation represents a critical molecular mechanism by which external signals can influence cell cycle progression through direct modification of Cdc25B activity and localization.

• How does Cdc25B contribute to G2/M transition at the molecular level?

  Cdc25B orchestrates the G2/M transition through a precise sequence of molecular events:

  1. During G2 phase, Cdc25B becomes dephosphorylated at key residues including Ser149

  2. This dephosphorylation allows Cdc25B to translocate from the cytoplasm to the nucleus

  3. In the nucleus, Cdc25B directly dephosphorylates Cdc2 (CDK1) at Tyr15

  4. Dephosphorylated Cdc2 forms an active complex with cyclin B (MPF)

  5. Activated MPF initiates mitotic events including nuclear envelope breakdown and chromosome condensation

  Research using phospho-deficient Cdc25B-S149A mutants demonstrates premature MPF activation and accelerated mitotic entry, confirming the inhibitory role of Ser149 phosphorylation in this process . Additionally, polo-like kinase 1 (PLK1) may work in parallel pathways, phosphorylating other Cdc25 family members (like Cdc25C at Ser198) to facilitate nuclear translocation and MPF activation .

Methodological Questions

• What are the optimal conditions for using Phospho-Cdc25b (Ser149) Antibody in Western blotting?

  For optimal Western blot results with Phospho-Cdc25b (Ser149) Antibody, follow these research-validated conditions:

  Sample Preparation:

  • Include phosphatase inhibitors in lysis buffer (e.g., Phosphatase inhibitor cocktail II, 25 mM NaF, 0.1 mM sodium orthovanadate, 25 mM β-glycerophosphate)

  • Use PMSF (1 mM) to inhibit proteases

  • Process samples quickly and maintain cold temperatures throughout

  Technical Parameters:

  • Dilution range: 1:500-1:1000

  • Expected molecular weight: ~62-65 kDa

  • Recommended blocking: 1-5% BSA in TBS-T (phospho-epitopes often require BSA instead of milk)

  • Secondary antibody options: Anti-Rabbit IgG conjugated to HRP, AP, FITC, or Biotin

  Critical Controls:

  • Positive control: G1/S phase cells with known Ser149 phosphorylation

  • Negative control: Phosphatase-treated lysate or S149A mutant expression

  • Loading control: β-actin or GAPDH

  Troubleshooting Tips:

  • If signal is weak, reduce washing stringency or increase antibody concentration

  • If background is high, increase washing stringency or reduce antibody concentration

  • For quantitative analysis, use densitometry software to normalize to loading controls

• How can I validate the specificity of Phospho-Cdc25b (Ser149) Antibody?

  Rigorous validation of phospho-specific antibodies is essential for reliable results. Implement these complementary approaches:

  1. Phosphatase Treatment: Divide your sample and treat half with lambda phosphatase. A specific phospho-antibody should show significantly reduced signal in treated samples.

  2. Competitive Inhibition: Pre-incubate antibody with the phosphopeptide immunogen (F-R-S(p)-L-P) before Western blotting. This should abolish specific binding.

  3. Genetic Validation:

     • Compare wild-type Cdc25B with S149A mutant expression

     • Perform siRNA knockdown of Cdc25B to demonstrate signal specificity

  4. Cell Cycle Synchronization: Since Ser149 phosphorylation is cell cycle-dependent, compare G1/S phase cells (high phosphorylation) with G2/M phase cells (low phosphorylation) .

  5. PKA Modulation: Treat cells with PKA inhibitors or activators to modulate Ser149 phosphorylation levels.

  6. Correlation with Localization: Verify that phospho-Ser149 signal correlates with cytoplasmic localization of Cdc25B .

  7. Mass Spectrometry Validation: Confirm phosphorylation site identity using LC-MS/MS analysis of immunoprecipitated protein .

  A comprehensive validation approach using multiple methods provides the highest confidence in antibody specificity and experimental results.

• What approaches can track Cdc25B-Ser149 phosphorylation dynamics during cell cycle progression?

  To effectively monitor the temporal dynamics of Cdc25B-Ser149 phosphorylation throughout the cell cycle, researchers can employ these advanced methodological approaches:

  1. Time-course Analysis in Synchronized Populations:

     • Synchronize cells using established methods (double thymidine block, nocodazole arrest/release)

     • Collect samples at defined intervals post-synchronization

     • Analyze by Western blotting with phospho-Ser149 antibody

     • Correlate with cell cycle markers (cyclins, phospho-H3) and DNA content

  2. Fertilized Mouse Egg Model:

     • Collection at defined timepoints after hCG injection represents specific cell cycle phases

     • The fertilized egg system provides natural synchronization without chemical perturbation

  3. Live Cell Imaging:

     • Express fluorescently-tagged Cdc25B constructs

     • Use phospho-specific biosensors to monitor phosphorylation status in real-time

     • Correlate with cell cycle phase transitions and nuclear envelope breakdown

  4. Flow Cytometry:

     • Combine DNA content analysis with intracellular phospho-Cdc25B staining

     • Provides single-cell resolution of phosphorylation status correlated with cell cycle phase

  5. MPF Activity Correlation:

     • Monitor Ser149 phosphorylation alongside histone H1 kinase assays

     • Establish precise timing relationships between phosphorylation changes and MPF activation

  These approaches provide complementary perspectives on how Ser149 phosphorylation is dynamically regulated throughout the cell cycle.

• How can I design experiments to investigate the functional consequences of Cdc25B-Ser149 phosphorylation?

  To rigorously investigate how Ser149 phosphorylation affects Cdc25B function, implement these experimental designs:

  1. Mutational Analysis:

     • Generate phospho-deficient (S149A) and phospho-mimetic (S149D) mutants

     • Express in appropriate cell systems or microinject mRNA into fertilized eggs

     • Compare effects on:

       • Cell cycle progression timing

       • MPF activation (histone H1 kinase assay)

       • Cdc2-Tyr15 phosphorylation patterns

       • Subcellular localization

  2. Interaction Studies:

     • Investigate 14-3-3ε binding to wild-type vs. mutant Cdc25B

     • Perform co-immunoprecipitation under varying cell cycle conditions

     • Use fluorescence colocalization to track interactions in situ

     • Create FRET-based sensors to monitor direct interactions in living cells

  3. PKA Modulation Experiments:

     • Manipulate PKA activity using activators (dbcAMP) or inhibitors

     • Monitor effects on Ser149 phosphorylation, localization, and function

     • Establish direct causal relationships between PKA activity and Cdc25B regulation

  4. Structure-Function Analysis:

     • Map the precise binding interface between phospho-Ser149 and 14-3-3ε

     • Identify additional proteins that recognize the phosphorylated motif

     • Determine how phosphorylation affects Cdc25B catalytic activity

  5. Cell Cycle Checkpoint Studies:

     • Analyze how Ser149 phosphorylation status affects response to checkpoint activation

     • Determine if Ser149 is targeted by checkpoint kinases under stress conditions

  These experimental approaches provide mechanistic insights into how Ser149 phosphorylation regulates Cdc25B function in normal cell cycle progression.

• What technical considerations are important when analyzing phosphorylation dynamics across different experimental systems?

  When studying Cdc25B-Ser149 phosphorylation across different experimental platforms, researchers should address these critical technical considerations:

  1. Species-Specific Epitope Conservation:

     • Most Phospho-Cdc25b (Ser149) antibodies target mouse Cdc25B

     • The epitope sequence (F-R-S(p)-L-P) should be verified for conservation across species

     • Cross-reactivity testing is essential when applying to human or other model systems

  2. Phospho-Epitope Preservation:

     • Rapid sample processing is critical to prevent post-lysis dephosphorylation

     • Include comprehensive phosphatase inhibitor cocktails in all buffers

     • Consider specialized phospho-protein preservation protocols for tissue specimens

  3. Quantitative Considerations:

     • Normalize phospho-Cdc25B signals to total Cdc25B protein levels

     • Account for cell cycle distribution differences between experimental systems

     • Use appropriate standards for cross-experiment comparisons

  4. System-Specific Controls:

     • For mouse embryos: defined time points post-hCG provide stage-specific controls

     • For cell lines: synchronized populations serve as phosphorylation standards

     • For tissues: cell cycle heterogeneity requires careful interpretation

  5. Physiological Context:

     • Cell-type specific regulators may affect Ser149 phosphorylation patterns

     • Growth conditions can influence PKA activity and resulting phosphorylation

     • Developmental timing may alter the significance of Ser149 phosphorylation

  6. Detection Method Optimization:

     • Signal amplification requirements vary between systems

     • Background reduction strategies must be tailored to each experimental context

     • Detection thresholds should be empirically determined for each system

  These technical considerations ensure reliable and reproducible analysis of Cdc25B-Ser149 phosphorylation across diverse experimental platforms.